Skip to main contentSkip to navigation
Sirius Investors
Galapagos N.V.

Galapagos N.V.

GLPG
NASDAQHealthcare

Galapagos N.V. (GLPG) Investment Research Dashboard

About Galapagos N.V. (GLPG) stock analysis

Get live GLPG stock price $27.98, comprehensive Galapagos N.V. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time GLPG stock data and investment insights.

27.98
1.71%Today
Market Cap
1.84B
Volume
2.38K
52W High
37.78
52W Low
24.74

Loading chart data...

Galapagos N.V. (GLPG) Overview

Galapagos N.V. (GLPG) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, GLPG trades at $27.98 with a market capitalization of 1.84B . Over the past 52 weeks, GLPG has traded between $24.74 and $37.78 , with the current price positioned at approximately 25% of this range . The stock currently trades at a pri...

Key Takeaways

  • Operates in the Healthcare sector (Biotechnology)
  • Market cap: 1.84B
  • Current price: $27.98
  • 52-week range: $24.74 - $37.78
  • P/E ratio: 3.21

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company ...

Company Information

CEO
Henry O. Gosebruch
Sector
Healthcare
Industry
Biotechnology
Employees
452

Contact Information

Address
Generaal De Wittelaan L11 A3
Country
BE

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Listed on major US exchange (NASDAQ) providing liquidity and transparency

Valuation metrics suggest potential value opportunity (P/E: 3.2)

Lower volatility stock (Beta: 0.30) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Galapagos N.V. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Galapagos N.V.
  • Investors should consider how Galapagos N.V. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

1.84B

P/E Ratio (TTM)

3.21

Beta

0.30

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

75/100 ⭐⭐⭐⭐⭐

Overall
+0.5%
NYSE
+0.6%
NASDAQ
+0.5%
Sector1D1W1MP/EScore
Financial Services+1.8%+2.8%+3.9%19.3
98/100⭐⭐⭐⭐⭐
Healthcare+0.5%+1.2%+1.4%24.0
75/100⭐⭐⭐⭐⭐
Communication Services+1.4%-0.6%+3.0%22.2
74/100⭐⭐⭐⭐⭐
Basic Materials+0.6%+1.4%-0.1%25.2
66/100⭐⭐⭐⭐
Consumer Defensive+0.2%+2.2%+1.1%29.8
64/100⭐⭐⭐⭐
Real Estate+0.4%+0.9%-1.6%29.5
51/100⭐⭐⭐
Energy-1.8%-3.4%-3.8%19.2
39/100⭐⭐
Utilities-0.8%+0.2%-4.2%26.8
37/100⭐⭐
Consumer Cyclical+0.3%-1.7%-6.0%42.8
18/100
Industrials+0.2%-0.0%-10.3%30.0
15/100
Technology+0.3%-1.9%-7.4%40.6
13/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.